Affordable Access

Cost utility of photodynamic therapy for predominantly classic neovascular age related macular degeneration.

Authors
  • Hopley, C
  • Salkeld, G
  • Mitchell, P
Type
Published Article
Journal
The British journal of ophthalmology
Publication Date
Aug 01, 2004
Volume
88
Issue
8
Pages
982–987
Identifiers
PMID: 15258009
Source
Medline
License
Unknown

Abstract

PDT treatment is the only available treatment for some forms of neovascular ("wet") AMD. Under these assumptions, PDT can be considered moderately cost effective for those with reasonable visual acuity but less cost effective for those with initial poor visual acuity. These findings have implications for ophthalmic practice and healthcare planning.

Report this publication

Statistics

Seen <100 times